Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, today announced the closing of a $400 million senior unsecured note offering by Oxford and Oxford Finance Co-Issuer II Inc., a wholly owned subsidiary of Oxford. The notes bear interest at a fixed rate of 6.375% and mature in 2027. Oxford intends to use the net proceeds of this offering to redeem its $300 million 6.375% Senior Notes due 2022 and repay a portion of its funding debt.

The notes were offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), that are qualified purchasers, as defined in Section 2(a)(51) of the Investment Company Act of 1940, as amended. The notes have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States or to U.S. persons absent registration or an applicable exemption from the registration requirements.

This press release does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the notes. The offering was made only by means of a confidential offering memorandum.

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. Since 2002, Oxford has originated approximately $8.8 billion in loans. Oxford is headquartered in Alexandria, Virginia, with additional offices in California (San Diego, Palo Alto, and Los Angeles), the greater Boston, Massachusetts area; and the greater New York, New York area. For more information, visit https://oxfordfinance.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220208005275/en/